The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 1, 2007, Pages 26-35

  Rutter, Martin K ^a,b,e   Nesto, Richard W ^c,d  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Manchester Diabetes Centre   (United Kingdom)

Author keywords

Coronary heart disease; Diabetes mellitus; Myocardial ischemia; Screening

Indexed keywords

ACCOUNTING; ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; EARLY DIAGNOSIS; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; NON INVASIVE PROCEDURE; PATIENT SELECTION; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SCREENING; SENSITIVITY ANALYSIS; SILENT MYOCARDIAL ISCHEMIA;

CORONARY ANGIOGRAPHY; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DIABETIC ANGIOPATHIES; EARLY DIAGNOSIS; GUIDELINES; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 33845755957     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0352     Document Type: Review

References (79)

1. Lauer M et al. (2005) Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 112: 771-776
2. Redberg RF et al. (2002) Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes. Circulation 105: e144-e152
3. Greenland P et al. (2001) Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 104: 1863-1867
4. Rubler S et al. (1987) Predictive value of clinical and exercise variables for detection of coronary artery disease in men with diabetes mellitus. Am J Cardiol 59: 1310-1313
5. Gaddi O et al. (1999) Diagnostic and prognostic value of vasodilator stress echocardiography in asymptomatic type 2 diabetic patients with positive exercise thallium scintigraphy: a pilot study. Diabet Med 16: 762-766
6. Inoguchi T et al. (2000) High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 47: 37-44
7. Rutter MK et al. (2002) Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 40: 56-61
8. De Lorenzo A et al. (2002) Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 90: 827-832
9. Gerson MC et al. (1988) Prediction of coronary artery disease in a population of insulin-requiring diabetic patients: results of an 8-year follow-up study. Am Heart J 116: 820-826
10. Torremocha F et al. (2001) Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients. Diabetes Metab 27: 49-57
11. Valensi P et al. (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24: 339-343
12. Jouven XX et al. (2002) Sudden death and diabetes mellitus: the role of parental antecedents in the Paris Prospective Study. J Am Coll Cardiol 39: 327A
13. Miettinen H et al. (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21: 69-75
14. Bellet S and Roman L (1967) The exercise test in diabetic patients as studied by radioelectrocardiography. Circulation 36: 245-254
15. Levitas IM and Kristal JJ (1972) Stress exercise testing of the young diabetic for the detection of unknown coronary artery disease. Isr J Med Sci 8: 845-847
16. Storstein L and Jervell J (1979) Response to bicycle exercise testing in long-standing juvenile diabetes. Acta Med Scand 205: 227-230
17. Abenavoli T et al. (1981) Exercise testing with myocardial scintigraphy in asymptomatic diabetic males. Circulation 63: 54-64
18. Hume L et al. (1986) Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men. Diabetes Care 9: 384-388
19. Rubler S and Fisher VJ (1985) The significance of repeated exercise testing with thallium-201 scanning in asymptomatic diabetic males. Clin Cardiol 8: 621-628
20. Lane SE et al. (1989) Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus. Am J Cardiol 64: 1275-1279
21. Boudreau RJ et al. (1990) Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology 175: 103-105
22. Koistinen MJ (1990) Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 301: 92-95
23. Nesto RW et al. (1990) Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy. Am Heart J 120: 1073-1077
24. Langer A et al. (1991) Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 67: 1073-1078
25. O'Sullivan JJ et al. (1991) Silent ischaemia in diabetic men with autonomic neuropathy. Brit Heart J 66: 313-315
26. Naka M et al. (1992) Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 123: 46-53
27. Paillole C et al. (1992) Non-invasive identification of severe coronary artery disease in patients with long-standing diabetes mellitus. Eur J Med 1: 464-468
28. Langer A et al. (1995) Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25: 610-618
29. Earle KA et al. (1996) Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia 39: 854-856
30. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group (1997) Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 79: 134-139
31. May O et al. (1997) Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res 34: 241-247
32. Valensi P et al. (1997) Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabetes Metab 23: 409-416
33. Griffin ME et al. (1998) Dobutamine stress echocardiography: false positive scans in proteinuric patients with type 1 diabetes mellitus at high risk of ischaemic heart disease. Diabet Med 15: 427-430
34. Janand-Delenne B et al. (1999) Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 22: 1396-1400
35. Rutter MK et al. (1999) Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with noninsulin-dependent diabetes mellitus. Am J Cardiol 83: 27-31
36. Thomas K et al. (1999) Prevalence of asymptomatic cardiac ischemia in men with diabetes mellitus type I. Ned Tijdschr Geneeskd 143: 2001-2006
37. Castells I et al. (2000) Inducible myocardial ischaemia in asymptomatic type 2 diabetic patients. Diabetes Res Clin Pract 49: 127-133
38. Sukhija R et al. (2000) Silent myocardial ischaemia in patients with type II diabetes mellitus and its relation with autonomic dysfunction. Indian Heart J 52: 540-546
39. Coisne D et al. (2001) Dobutamine stress echocardiography response of asymptomatic patients with diabetes. Echocardiography 18: 373-379
40. Penfornis A et al. (2001) Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med 18: 900-905
41. Valensi P et al. (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24: 339-343
42. Al-Attar AT et al. (2002) Cardiac tests in asymptomatic type 2 diabetics. Med Princ Pract 11: 171-175
43. Bacci S et al. (2002) The role of dobutamine stress echocardiography in detecting severe coronary artery disease in asymptomatic at high risk type 2 diabetic patients. Diabetes Care 25: 1659
44. Bacci S et al. (2002) Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 147: 649-654
45. Faglia E et al. (2002) Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 25: 2032-2036
46. Larsen J et al. (2002) Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51: 2637-2641
47. Cosson E et al. (2003) Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events? Diabetes Metab 29: 470-476
48. Gokcel A et al. (2003) Silent coronary artery disease in patients with type 2 diabetes mellitus. Acta Diabetol 40: 176-180
49. Araz M et al. (2004) Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control. Acta Diabetol 41: 38-43
50. Cosson E et al. (2004) Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med 21: 342-348
51. Miller TD et al. (2004) Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 147: 890-896
52. Zellweger MJ et al. (2004) Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 25: 543-550
53. Sultan A et al. (2004) Risk factors for silent myocardial ischemia in high-risk type 1 diabetic patients. Diabetes Care 27: 1745-1747
54. 1c with prevalence of silent myocardial ischemia. Am J Cardiol 95: 1472-1474
55. Faglia E et al. (2005) Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 149: e1-e6
56. Le Feuvre CL et al. (2005) Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes. Diabetes Metab 31: 135-142
57. Rajagopalan N et al. (2005) Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 45: 43-49
58. Senior PA et al. (2005) Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates. Diabetes Care 28: 866-872
59. Wackers FJ et al. (2004) Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27: 1954-1961
60. Coisne D et al. (2001) Dobutamine stress echocardiography response of asymptomatic patients with diabetes. Echocardiography 18: 373-379
61. Penfornis A et al. (2001) Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med 18: 900-905
62. Ramanathan V et al. (2005) Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation 79: 1453-1458
63. American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21: 1551-1559
64. Giri S et al. (2002) Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105: 32-40
65. Hachamovitch R et al. (2003) Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 41: 1329-1340
66. Manske CL et al. (1992) Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340: 998-1002
67. Passa P et al. (1995) Coronary disease and diabetes. Diabetes Metab 21: 446-451
68. Gibbons RJ et al. (2002) ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 106: 1883-1892
69. Eagle KA et al. (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105: 1257-1267
70. Klocke FJ et al. (2003) ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 108: 1404-1418
71. Grundy SM et al. (2002) Prevention conference VI: diabetes and cardiovascular disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 105: 2231-2239
72. U.S. Preventive Services Task Force (2004) Screening for coronary heart disease: recommendation statement. Ann Intern Med 140: 569-572
73. Fowler-Brown A et al. (2004) Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med 140: W9-W24
74. Kang X et al. (1999) Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 138: 1025-1032
75. Kamalesh M et al. (2002) Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J 143: 163-168
76. Anonymous (1992) Asymptomatic Cardiac Ischemia Pilot study (ACIP). Am J Cardiol 70: 744-747
77. Pepine CJ et al. (1994) Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 90: 762-768
78. Jonas M et al. (1996) Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol 77: 1273-1277
79. Gheorghiade M and Bonow RO (1996) Coronary Artery Disease. In Textbook of Internal Medicine, 428-448 (Ed. Kelly W) Philadelphia: Lippincott Williams & Wilkins